NPI-verified accounts for pain management and physical medicine
Precision Biologics opens accounts only for licensed physicians and clinics operating under physician supervision, confirmed through NPI verification against the NPPES registry. This step applies the same way whether the ordering clinic focuses on interventional pain management or physical medicine and rehabilitation.
Because exosome products are generally regulated as biologic drugs with no FDA-approved exosome product on the market, the decision to purchase and any decision about clinical use remains with the ordering physician and that physician's own regulatory counsel.
Phoenix
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
269- Pain Medicine
- 124
- Physical Medicine & Rehabilitation
- 145
Receiving and cold chain in the Phoenix area
Cryopreserved Wharton's jelly products ship overnight on dry ice in validated containers and go into -80 degree C storage immediately on arrival. Clinics generally assign a specific staff member to receive, log by lot number, and store these shipments without delay.
Lyophilized exosome and Wharton's jelly formats are shelf-stable under normal storage conditions and ship without the cryogenic packaging step, which some clinics prefer for simpler receiving logistics.
Verification with the Arizona Medical Board and counsel
Before adding a new biologics product to a pain management or physical medicine practice, most groups confirm their regulatory posture with the Arizona Medical Board or the applicable osteopathic board, and with independent counsel, particularly for exosome products that fall outside the 361 HCT/P framework.
Precision Biologics does not make this determination on a clinic's behalf and does not advise on clinical use, indications, or protocols.
How Precision Biologics supports onboarding
New accounts receive access to peer-to-peer calls between physicians focused on product documentation rather than clinical guidance, along with a certificate of analysis, donor eligibility summary, and lot release record on request for each lot ordered.
These products are not FDA approved or licensed for any disease or condition. Information on this page is for licensed healthcare professionals and is not medical or legal advice.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Is Bio Xsomes regulated the same way as Wharton's jelly products?+
No. Exosome products like Bio Xsomes are generally regulated as biologic drugs under section 351, not under the 361 HCT/P framework used for Wharton's jelly products. Clinics should review this distinction with their own counsel.
What is required to open an account in Phoenix?+
A licensed physician's NPI number, verified against the NPPES registry. Clinics operating under physician supervision are set up through that physician's verification.
Can we request documentation before placing a first order?+
Yes. Verified accounts can request a certificate of analysis, donor eligibility summary, and lot release record ahead of any order.